Rockwell Medical Expects FY2024 Sales Of $84M-$88M Compared To Consensus Of $98.01M, With Gross Margin Of 14%-16%, And For The Company To Be Profitable On An Adjusted EBITDA Basis For The Full-year 2024
Portfolio Pulse from Benzinga Newsdesk
Rockwell Medical forecasts FY2024 sales to be between $84M-$88M, below the consensus estimate of $98.01M. The company anticipates a gross margin of 14%-16% and expects to achieve profitability on an adjusted EBITDA basis for the full year 2024.
March 21, 2024 | 10:06 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Rockwell Medical forecasts lower-than-expected FY2024 sales but expects to be profitable on an adjusted EBITDA basis.
The projected sales being below consensus estimates could negatively impact investor sentiment in the short term, leading to a potential decrease in stock price. However, the expectation of profitability on an adjusted EBITDA basis might mitigate some of the negative impact.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100